Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with <i>T790M</i> mutations
Yuehong Wang(Zhejiang University), Faye M. Johnson(The University of Texas MD Anderson Cancer Center)
Cited by 24
Related Papers
Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase–STAT3 Binding
|Cancer Research|2009|131
Reciprocal Regulation of c-Src and STAT3 in Non-Small Cell Lung Cancer
|Clinical Cancer Research|2009|118
Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines
|Oncotarget|2017|70
STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma
|Clinical Cancer Research|2011|68
PDK1 Mediates <i>NOTCH1</i> -Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition
|Clinical Cancer Research|2019|51